Skip to content

Avantor AVTR Operating Cash Flow

Operating Cash Flow at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$1.19B+64.9%
Danaher logo
DanaherDHR
$1.32B+1.8%
Agilent Technologies logo
Agilent TechnologiesA
$277M+25.3%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$89.9M-30.5%
Element Solutions logo
Element SolutionsESI
-$66.6M-356%
Westlake logo
WestlakeWLK
-$94M-22.1%

Other financials

Income statement

See full
Revenue$1.6B0.0%
Gross profit$500.7M-6.4%
Operating income$99.5M-32.5%
Net income$43.3M-32.9%
EPS (diluted)$0.06-33.3%

Balance sheet

See full
Cash & equivalents$282.2M-11.4%
Total debt$3.8B-7.1%
Total equity$5.6B-8.4%
Total assets$11.7B-5.4%

Cash flow

See full
CapEx$33.5M+19.6%
Free cash flow$25.2M-69.0%

Valuation

See full
Market cap$6.54B-52.0%
Enterprise value$10.07B-40.4%
P/S-1.0×

Profitability

See full
Gross margin32.1%-1.4pp
Operating margin4%-5.2pp
Net margin-9.2%-19.9pp
FCF margin6.7%-3.3pp

Returns & leverage

See full
Return on equity-10.3%-22.8pp
Debt / equity0.7×0.0×
Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avantor's operating cash flow?
Avantor (AVTR) reported operating cash flow of $58.7M in Q1 2026.
How has Avantor's operating cash flow changed year-over-year?
Avantor's operating cash flow decreased by 46.3% year-over-year, from $109.3M to $58.7M.
What is the long-term trend for Avantor's operating cash flow?
Over 4 years (2021 to 2025), Avantor's operating cash flow has grown at a -10.1% compound annual growth rate (CAGR), from $953.6M to $623.8M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.